NOVARTIS PHARMA AG

13D and 13G Filings

13D/G filings
13G on 2 securities
CIK
0001030617
All SEC filings
View on sec.gov
Issuer % of Class Filed
Precision BioSciences, Inc. 13G/A Amendment 2
DTIL · 74019P207
3.7% 8/6/2025
Event 6/30/2025
Erasca, Inc. 13G/A Amendment 1
ERAS · 29479A108
4.4% 2/12/2025
Event 12/31/2024
Precision BioSciences, Inc. 13G/A Amendment 1
DTIL · 74019P207
5.4% 2/12/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.